SANXING(SH:601567) Xin Lang Cai Jing·2025-11-12 02:26Group 1 - Samsung Medical experienced a 5% decline in stock price, trading at 27.34 CNY per share, with a total transaction volume of 676 million CNY and a turnover rate of 1.71%, resulting in a total market capitalization of 38.418 billion CNY [1] - The company, Ningbo Samsung Medical Electric Co., Ltd., was established on February 1, 2007, and listed on June 15, 2011. Its main business involves the research, production, and sales of electric energy metering and information collection products, as well as distribution equipment and medical services [1] - The revenue composition of Samsung Medical includes 79.70% from the electric power sector, 19.15% from medical services, and 1.15% from other businesses, with no revenue from financing leasing and consulting services [1] Group 2 - Citic Prudential Fund has one fund heavily invested in Samsung Medical, specifically the Citic Prudential Emerging Industries Mixed A Fund (000209), which held 2.5721 million shares in the third quarter, unchanged from the previous period, accounting for 3.3% of the fund's net value [2] - The Citic Prudential Emerging Industries Mixed A Fund was established on July 17, 2013, with a latest scale of 1.839 billion CNY. Year-to-date returns are 30.86%, ranking 2777 out of 8147 in its category, while the one-year return is 19.45%, ranking 3450 out of 8056 [2] - The fund manager, Sun Haozhong, has been in the position for 5 years and 325 days, with a total asset scale of 3.145 billion CNY. The best fund return during his tenure is 77.62%, while the worst return is -55% [3]